APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Essential Hypertension Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Essential Hypertension Drugs Industry Growth and Trends Forecast to 2032

Report ID 173989650122 December 2025114 pages

Choose your research edition.

Industry ResearchEssential Hypertension Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Essential Hypertension Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Essential Hypertension Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Essential Hypertension Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Essential Hypertension Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Essential Hypertension Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Essential Hypertension Drugs market include Chengdu Easton Biopharmaceuticals, Shanghai Shyndec Pharmaceutical, Sanofi, Qingdao Huanghai Pharmaceutical, Novartis, Merck, Jiangsu Jibeier Pharmaceutical, Pfizer and CR Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Essential Hypertension Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Essential Hypertension Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Essential Hypertension Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Essential Hypertension Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Essential Hypertension Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Essential Hypertension Drugs Market by Company

Chengdu Easton Biopharmaceuticals

Shanghai Shyndec Pharmaceutical

Sanofi

Qingdao Huanghai Pharmaceutical

Novartis

Merck

Jiangsu Jibeier Pharmaceutical

Pfizer

CR Double-Crane

Huahai Pharmaceutical

Tianjin Pharmaceutical Da Ren Tang Group

Boehringer Ingelheim

Bayer

AstraZeneca

Lupin Pharmaceuticals

Essential Hypertension Drugs Segment by Type

ACE Inhibitors

Beta Blockers

Calcium Channel Blockers

Diuretics

Angiotensin II Receptor Blockers

Others

Essential Hypertension Drugs Segment by Application

Hospital

Clinic

Others

Essential Hypertension Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Essential Hypertension Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Essential Hypertension Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Essential Hypertension Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Essential Hypertension Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Essential Hypertension Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Essential Hypertension Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Essential Hypertension Drugs Market Share by Region (2021-2026) Table 4. Global Essential Hypertension Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Essential Hypertension Drugs Market Share by Region (2027-2032) Table 6. Global Essential Hypertension Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Essential Hypertension Drugs Market Size Share by Type (2021-2026) Table 9. Global Essential Hypertension Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Essential Hypertension Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Essential Hypertension Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Essential Hypertension Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Essential Hypertension Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Essential Hypertension Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Essential Hypertension Drugs Market Size Share by Application (2021-2026) Table 24. Global Essential Hypertension Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Essential Hypertension Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Essential Hypertension Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Essential Hypertension Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Essential Hypertension Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Essential Hypertension Drugs Industry Trends Table 37. Essential Hypertension Drugs Industry Drivers Table 38. Essential Hypertension Drugs Industry Opportunities and Challenges Table 39. Essential Hypertension Drugs Industry Restraints Table 40. Global Essential Hypertension Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Essential Hypertension Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Essential Hypertension Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Essential Hypertension Drugs Key Company Headquarters & Area Served Table 44. Global Essential Hypertension Drugs Company, Product Type & Application Table 45. Global Essential Hypertension Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Essential Hypertension Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Chengdu Easton Biopharmaceuticals Company Information Table 49. Chengdu Easton Biopharmaceuticals Business Overview Table 50. Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Product Portfolio Table 52. Chengdu Easton Biopharmaceuticals Recent Development Table 53. Shanghai Shyndec Pharmaceutical Company Information Table 54. Shanghai Shyndec Pharmaceutical Business Overview Table 55. Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 57. Shanghai Shyndec Pharmaceutical Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Essential Hypertension Drugs Product Portfolio Table 62. Sanofi Recent Development Table 63. Qingdao Huanghai Pharmaceutical Company Information Table 64. Qingdao Huanghai Pharmaceutical Business Overview Table 65. Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 67. Qingdao Huanghai Pharmaceutical Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Essential Hypertension Drugs Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Merck Essential Hypertension Drugs Product Portfolio Table 77. Merck Recent Development Table 78. Jiangsu Jibeier Pharmaceutical Company Information Table 79. Jiangsu Jibeier Pharmaceutical Business Overview Table 80. Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 82. Jiangsu Jibeier Pharmaceutical Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pfizer Essential Hypertension Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. CR Double-Crane Company Information Table 89. CR Double-Crane Business Overview Table 90. CR Double-Crane Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. CR Double-Crane Essential Hypertension Drugs Product Portfolio Table 92. CR Double-Crane Recent Development Table 93. Huahai Pharmaceutical Company Information Table 94. Huahai Pharmaceutical Business Overview Table 95. Huahai Pharmaceutical Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Huahai Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 97. Huahai Pharmaceutical Recent Development Table 98. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 99. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 100. Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Product Portfolio Table 102. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Essential Hypertension Drugs Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bayer Essential Hypertension Drugs Product Portfolio Table 112. Bayer Recent Development Table 113. AstraZeneca Company Information Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AstraZeneca Essential Hypertension Drugs Product Portfolio Table 117. AstraZeneca Recent Development Table 118. Lupin Pharmaceuticals Company Information Table 119. Lupin Pharmaceuticals Business Overview Table 120. Lupin Pharmaceuticals Essential Hypertension Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Lupin Pharmaceuticals Essential Hypertension Drugs Product Portfolio Table 122. Lupin Pharmaceuticals Recent Development Table 123. North America Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Essential Hypertension Drugs Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Essential Hypertension Drugs Market Share by Country (2021-2026) Table 126. North America Essential Hypertension Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Essential Hypertension Drugs Market Share Forecast by Country (2027-2032) Table 128. Europe Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Essential Hypertension Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Essential Hypertension Drugs Market Share by Country (2021-2026) Table 131. Europe Essential Hypertension Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Essential Hypertension Drugs Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Essential Hypertension Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Essential Hypertension Drugs Market Share by Country (2021-2026) Table 136. Asia-Pacific Essential Hypertension Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Essential Hypertension Drugs Market Share Forecast by Country (2027-2032) Table 138. Latin America Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Essential Hypertension Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Essential Hypertension Drugs Market Share by Country (2021-2026) Table 141. Latin America Essential Hypertension Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Essential Hypertension Drugs Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Essential Hypertension Drugs Market Share by Country (2021-2026) Table 146. Middle East & Africa Essential Hypertension Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Essential Hypertension Drugs Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Essential Hypertension Drugs Product Image Figure 3. Global Essential Hypertension Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Essential Hypertension Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Essential Hypertension Drugs Market Share by Region (2021-2032) Figure 7. North America Essential Hypertension Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Essential Hypertension Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Essential Hypertension Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Essential Hypertension Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Essential Hypertension Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. ACE Inhibitors Image Figure 13. Global ACE Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Beta Blockers Image Figure 15. Global Beta Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Calcium Channel Blockers Image Figure 17. Global Calcium Channel Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Diuretics Image Figure 19. Global Diuretics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Angiotensin II Receptor Blockers Image Figure 21. Global Angiotensin II Receptor Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Essential Hypertension Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Essential Hypertension Drugs Market Share by Type 2025 VS 2032 Figure 26. North America Essential Hypertension Drugs Market Size Share by Type (2021-2032) Figure 27. Europe Essential Hypertension Drugs Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Essential Hypertension Drugs Market Size Share by Type (2021-2032) Figure 29. Latin America Essential Hypertension Drugs Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Essential Hypertension Drugs Market Size Share by Type (2021-2032) Figure 31. Hospital Image Figure 32. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Clinic Image Figure 34. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Essential Hypertension Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Essential Hypertension Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Essential Hypertension Drugs Market Size Share by Application (2021-2032) Figure 40. Europe Essential Hypertension Drugs Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Essential Hypertension Drugs Market Size Share by Application (2021-2032) Figure 42. Latin America Essential Hypertension Drugs Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Essential Hypertension Drugs Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Essential Hypertension Drugs Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Essential Hypertension Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Essential Hypertension Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 49. Europe Essential Hypertension Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Essential Hypertension Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 52. Asia-Pacific Essential Hypertension Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Essential Hypertension Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 55. Latin America Essential Hypertension Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Essential Hypertension Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 58. Middle East & Africa Essential Hypertension Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Essential Hypertension Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • ACE Inhibitors
  • Beta Blockers
  • Calcium Channel Blockers
  • Diuretics
  • Angiotensin II Receptor Blockers
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chengdu Easton Biopharmaceuticals
  • Shanghai Shyndec Pharmaceutical
  • Sanofi
  • Qingdao Huanghai Pharmaceutical
  • Novartis
  • Merck
  • Jiangsu Jibeier Pharmaceutical
  • Pfizer
  • CR Double-Crane
  • Huahai Pharmaceutical
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Boehringer Ingelheim
  • Bayer
  • AstraZeneca
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Essential Hypertension Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Essential Hypertension Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Essential Hypertension Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Essential Hypertension Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Essential Hypertension Drugs Market Size (2021-2032)
  8. 1.5.1 North America Essential Hypertension Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Essential Hypertension Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Essential Hypertension Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Essential Hypertension Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Essential Hypertension Drugs Market Size Growth Rate (2021-2032)
2 Essential Hypertension Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 ACE Inhibitors
  3. 2.1.2 Beta Blockers
  4. 2.1.3 Calcium Channel Blockers
  5. 2.1.4 Diuretics
  6. 2.1.5 Angiotensin II Receptor Blockers
  7. 2.1.6 Others
  8. 2.2 Global Essential Hypertension Drugs Market Size by Type
  9. 2.2.1 Global Essential Hypertension Drugs Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Essential Hypertension Drugs Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Essential Hypertension Drugs Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Essential Hypertension Drugs Market Size by Regions
  13. 2.3.1 North America Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Type (2021-2026)
3 Essential Hypertension Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Essential Hypertension Drugs Market Size by Application
  6. 3.2.1 Global Essential Hypertension Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Essential Hypertension Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Essential Hypertension Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Essential Hypertension Drugs Market Size by Regions
  10. 3.3.1 North America Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Essential Hypertension Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Essential Hypertension Drugs Industry Trends
  2. 4.2 Essential Hypertension Drugs Industry Drivers
  3. 4.3 Essential Hypertension Drugs Industry Opportunities and Challenges
  4. 4.4 Essential Hypertension Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Essential Hypertension Drugs Revenue (2021-2026)
  2. 5.2 Global Essential Hypertension Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Essential Hypertension Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Essential Hypertension Drugs Company, Product Type & Application
  5. 5.5 Global Essential Hypertension Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Essential Hypertension Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Essential Hypertension Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Essential Hypertension Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Chengdu Easton Biopharmaceuticals
  2. 6.1.1 Chengdu Easton Biopharmaceuticals Company Information
  3. 6.1.2 Chengdu Easton Biopharmaceuticals Business Overview
  4. 6.1.3 Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Product Portfolio
  6. 6.1.5 Chengdu Easton Biopharmaceuticals Recent Developments
  7. 6.2 Shanghai Shyndec Pharmaceutical
  8. 6.2.1 Shanghai Shyndec Pharmaceutical Company Information
  9. 6.2.2 Shanghai Shyndec Pharmaceutical Business Overview
  10. 6.2.3 Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Product Portfolio
  12. 6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Essential Hypertension Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Qingdao Huanghai Pharmaceutical
  20. 6.4.1 Qingdao Huanghai Pharmaceutical Company Information
  21. 6.4.2 Qingdao Huanghai Pharmaceutical Business Overview
  22. 6.4.3 Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Product Portfolio
  24. 6.4.5 Qingdao Huanghai Pharmaceutical Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Essential Hypertension Drugs Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Merck Essential Hypertension Drugs Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Jiangsu Jibeier Pharmaceutical
  38. 6.7.1 Jiangsu Jibeier Pharmaceutical Company Information
  39. 6.7.2 Jiangsu Jibeier Pharmaceutical Business Overview
  40. 6.7.3 Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Product Portfolio
  42. 6.7.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Essential Hypertension Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 CR Double-Crane
  50. 6.9.1 CR Double-Crane Company Information
  51. 6.9.2 CR Double-Crane Business Overview
  52. 6.9.3 CR Double-Crane Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 CR Double-Crane Essential Hypertension Drugs Product Portfolio
  54. 6.9.5 CR Double-Crane Recent Developments
  55. 6.10 Huahai Pharmaceutical
  56. 6.10.1 Huahai Pharmaceutical Company Information
  57. 6.10.2 Huahai Pharmaceutical Business Overview
  58. 6.10.3 Huahai Pharmaceutical Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Huahai Pharmaceutical Essential Hypertension Drugs Product Portfolio
  60. 6.10.5 Huahai Pharmaceutical Recent Developments
  61. 6.11 Tianjin Pharmaceutical Da Ren Tang Group
  62. 6.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  63. 6.11.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  64. 6.11.3 Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Product Portfolio
  66. 6.11.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Essential Hypertension Drugs Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Bayer
  74. 6.13.1 Bayer Company Information
  75. 6.13.2 Bayer Business Overview
  76. 6.13.3 Bayer Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bayer Essential Hypertension Drugs Product Portfolio
  78. 6.13.5 Bayer Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AstraZeneca Essential Hypertension Drugs Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Lupin Pharmaceuticals
  86. 6.15.1 Lupin Pharmaceuticals Company Information
  87. 6.15.2 Lupin Pharmaceuticals Business Overview
  88. 6.15.3 Lupin Pharmaceuticals Essential Hypertension Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Lupin Pharmaceuticals Essential Hypertension Drugs Product Portfolio
  90. 6.15.5 Lupin Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Essential Hypertension Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Essential Hypertension Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Essential Hypertension Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Essential Hypertension Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Essential Hypertension Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Essential Hypertension Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Essential Hypertension Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Essential Hypertension Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Essential Hypertension Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst